Takeda wins over Shire for $62 billion

Takeda Pharmaceutical Company Ltd has won the agreement of Shire Plc to a takeover that values the Ireland-based company at $62 billion and will potentially strengthen Takeda’s position in the US. Although headquartered in Dublin, Shire generates most of its business from the US.

Full text available to subscribers only. Click here for information on subscribing to MedNous.